Literature DB >> 8821093

Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment.

R Radinsky1.   

Abstract

The mechanistic basis of a metastatic cell's ability to proliferate in the parenchyma of certain organs and develop organ-specific metastases is under intense investigation. Signals from paracrine or autocrine pathways, alone or in combination, may regulate tumor cell proliferation with the eventual outcome dependent on the net balance of stimulatory and inhibitory factors. This article summarizes recent reports from our laboratory and others demonstrating that the organ microenvironment can profoundly influence the pattern of gene expression and the biological phenotype of metastatic tumor cells, including induction of melanocyte stimulating hormone receptor and production of melanin, regulation of terminal differentiation and apoptosis, resistance to chemotherapy, and regulation of growth at the organ-specific metastatic site. These recent data from both murine and human tumor models support the concept that the microenvironment of different organs can influence the pattern of gene expression and hence the phenotype of tumor cells at different steps of the metastatic process. These findings have obvious implications for the therapy of neoplasms in general and metastases in particular.

Entities:  

Mesh:

Year:  1995        PMID: 8821093     DOI: 10.1007/bf00690601

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  135 in total

1.  Expression of melanocyte stimulating hormone receptors correlates with mammalian pigmentation, and can be modulated by interferons.

Authors:  K Kameyama; P M Montague; V J Hearing
Journal:  J Cell Physiol       Date:  1988-10       Impact factor: 6.384

2.  The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues.

Authors:  J M Croop; M Raymond; D Haber; A Devault; R J Arceci; P Gros; D E Housman
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

3.  In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice.

Authors:  K Morikawa; S M Walker; J M Jessup; I J Fidler
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

Review 4.  Signaling mechanisms controlled by melanocortins in melanoma, lacrimal, and brain astroglial cells.

Authors:  Y Salomon; M Zohar; J O Dejordy; Y Eshel; I Shafir; H Leiba; N B Garty; J Schmidt-Sole; A Azrad; E Shai
Journal:  Ann N Y Acad Sci       Date:  1993-05-31       Impact factor: 5.691

5.  Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.

Authors:  G Shaulsky; N Goldfinger; V Rotter
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

Review 6.  EGF receptor in neoplasia and metastasis.

Authors:  K Khazaie; V Schirrmacher; R B Lichtner
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

7.  Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer.

Authors:  J R Sainsbury; J R Farndon; G V Sherbet; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

8.  Influence of organ microenvironment on pigmentation of a metastatic murine melanoma.

Authors:  J E Price; D Tarin; I J Fidler
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

Review 9.  The role of trophic factors and autocrine/paracrine growth factors in brain metastasis.

Authors:  D G Menter; J L Herrmann; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

10.  Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines.

Authors:  J G Park; B S Kramer; S L Lai; L J Goldstein; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1990-02-07       Impact factor: 13.506

View more
  29 in total

Review 1.  Prostaglandins and cancer.

Authors:  D Wang; R N Dubois
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

2.  The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells.

Authors:  Futoshi Okada; Masanobu Kobayashi; Hiroki Tanaka; Tokushige Kobayashi; Hiroshi Tazawa; Yoshihito Iuchi; Kunishige Onuma; Masuo Hosokawa; Mary C Dinauer; Nicholas H Hunt
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Mathematical model of the role of intercellular signalling in intercellular cooperation during tumorigenesis.

Authors:  S Ghosh; S Elankumaran; I K Puri
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 4.  Role of pHi, and proton transporters in oncogene-driven neoplastic transformation.

Authors:  Stephan Joel Reshkin; Maria Raffaella Greco; Rosa Angela Cardone
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

5.  Diminution of the development of experimental metastases produced by murine metastatic lines in essential fatty acid-deficient host mice.

Authors:  A Mannini; L Calorini; G Mugnai; S Ruggieri
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

Review 6.  Mouse models of metastatic pancreatic adenocarcinoma.

Authors:  K Xie; B Wang; Q Shi; J L Abbruzzese; Q Xiong; X Le
Journal:  Int J Pancreatol       Date:  2001

7.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.

Authors:  K J Luzzi; I C MacDonald; E E Schmidt; N Kerkvliet; V L Morris; A F Chambers; A C Groom
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

8.  Gene expression profiles of primary breast tumors maintained in distant metastases.

Authors:  Britta Weigelt; Annuska M Glas; Lodewyk F A Wessels; Anke T Witteveen; Johannes L Peterse; Laura J van't Veer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

9.  Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Authors:  M Fakih; M Vincent
Journal:  Curr Oncol       Date:  2010-07       Impact factor: 3.677

10.  Reduction of anion exchanger 2 expression induces apoptosis of human hepatocellular carcinoma cells.

Authors:  Jin-Ming Hwang; Shao-Hsuan Kao; Yi-Hsien Hsieh; Kuen-Lin Li; Pei-Hsi Wang; Li-Song Hsu; Jer-Yuh Liu
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.